Aurinia Pharmaceuticals Inc
(NASDAQ:AUPH)
$9.17
0.12[1.33%]
Last update: 3:03PM (Delayed 15-Minutes)
Get Real Time Here
Day Range8.871 - 9.22052 Wk Range4.070 - 20.475Open / Close9.100 / -Float / Outstanding141.687M / 142.110M
Vol / Avg.1.377M / 3.117MMkt Cap1.303BP/E-50d Avg. Price6.080
Div / Yield (Forward)- / -%Payout Ratio-Total Float141.687MEPS-0.830

Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary

Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.

Loading...
Day Range8.871 - 9.22052 Wk Range4.070 - 20.475Open / Close9.100 / -Float / Outstanding141.687M / 142.110M
Vol / Avg.1.377M / 3.117MMkt Cap1.303BP/E-50d Avg. Price6.080
Div / Yield (Forward)- / -%Payout Ratio-Total Float141.687MEPS-0.830
Adam Eckert - Jul 26, 2022, 3:50PM
InvestorsObserver - Jan 25, 2023, 5:50AM
Seeking Alpha - Nov 2, 2022, 1:41PM
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS-0.170-0.060 0.1100
REV36.180M55.779M19.599M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Aurinia Pharmaceuticals (AUPH) stock?

A

You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aurinia Pharmaceuticals's (AUPH) competitors?

A

There are no as such competitors for Aurinia Pharmaceuticals.

Q

What is the target price for Aurinia Pharmaceuticals (AUPH) stock?

A

The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Aurinia Pharmaceuticals (AUPH)?

A

The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.

Q

Does Aurinia Pharmaceuticals (AUPH) pay a dividend?

A

There are no upcoming dividends for Aurinia Pharmaceuticals.

Q

When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?

A

Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is Aurinia Pharmaceuticals (AUPH) going to split?

A

There is no upcoming split for Aurinia Pharmaceuticals.

Q

What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?

A

Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary

Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.

Loading...
Day Range8.871 - 9.22052 Wk Range4.070 - 20.475Open / Close9.100 / -Float / Outstanding141.687M / 142.110M
Vol / Avg.1.377M / 3.117MMkt Cap1.303BP/E-50d Avg. Price6.080
Div / Yield (Forward)- / -%Payout Ratio-Total Float141.687MEPS-0.830
Adam Eckert - Jul 26, 2022, 3:50PM
InvestorsObserver - Jan 25, 2023, 5:50AM
Seeking Alpha - Nov 2, 2022, 1:41PM
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS-0.170-0.060 0.1100
REV36.180M55.779M19.599M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Aurinia Pharmaceuticals (AUPH) stock?

A

You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aurinia Pharmaceuticals's (AUPH) competitors?

A

There are no as such competitors for Aurinia Pharmaceuticals.

Q

What is the target price for Aurinia Pharmaceuticals (AUPH) stock?

A

The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Aurinia Pharmaceuticals (AUPH)?

A

The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.

Q

Does Aurinia Pharmaceuticals (AUPH) pay a dividend?

A

There are no upcoming dividends for Aurinia Pharmaceuticals.

Q

When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?

A

Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is Aurinia Pharmaceuticals (AUPH) going to split?

A

There is no upcoming split for Aurinia Pharmaceuticals.

Q

What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?

A

Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary

Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.

Loading...
Day Range8.871 - 9.22052 Wk Range4.070 - 20.475Open / Close9.100 / -Float / Outstanding141.687M / 142.110M
Vol / Avg.1.377M / 3.117MMkt Cap1.303BP/E-50d Avg. Price6.080
Div / Yield (Forward)- / -%Payout Ratio-Total Float141.687MEPS-0.830
Adam Eckert - Jul 26, 2022, 3:50PM
InvestorsObserver - Jan 25, 2023, 5:50AM
Seeking Alpha - Nov 2, 2022, 1:41PM
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS-0.170-0.060 0.1100
REV36.180M55.779M19.599M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Aurinia Pharmaceuticals (AUPH) stock?

A

You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aurinia Pharmaceuticals's (AUPH) competitors?

A

There are no as such competitors for Aurinia Pharmaceuticals.

Q

What is the target price for Aurinia Pharmaceuticals (AUPH) stock?

A

The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Aurinia Pharmaceuticals (AUPH)?

A

The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.

Q

Does Aurinia Pharmaceuticals (AUPH) pay a dividend?

A

There are no upcoming dividends for Aurinia Pharmaceuticals.

Q

When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?

A

Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is Aurinia Pharmaceuticals (AUPH) going to split?

A

There is no upcoming split for Aurinia Pharmaceuticals.

Q

What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?

A

Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary

Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.

Loading...
Day Range8.871 - 9.22052 Wk Range4.070 - 20.475Open / Close9.100 / -Float / Outstanding141.687M / 142.110M
Vol / Avg.1.377M / 3.117MMkt Cap1.303BP/E-50d Avg. Price6.080
Div / Yield (Forward)- / -%Payout Ratio-Total Float141.687MEPS-0.830
Adam Eckert - Jul 26, 2022, 3:50PM
InvestorsObserver - Jan 25, 2023, 5:50AM
Seeking Alpha - Nov 2, 2022, 1:41PM
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS-0.170-0.060 0.1100
REV36.180M55.779M19.599M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Aurinia Pharmaceuticals (AUPH) stock?

A

You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aurinia Pharmaceuticals's (AUPH) competitors?

A

There are no as such competitors for Aurinia Pharmaceuticals.

Q

What is the target price for Aurinia Pharmaceuticals (AUPH) stock?

A

The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Aurinia Pharmaceuticals (AUPH)?

A

The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.

Q

Does Aurinia Pharmaceuticals (AUPH) pay a dividend?

A

There are no upcoming dividends for Aurinia Pharmaceuticals.

Q

When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?

A

Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is Aurinia Pharmaceuticals (AUPH) going to split?

A

There is no upcoming split for Aurinia Pharmaceuticals.

Q

What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?

A

Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary

Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.

Loading...
Day Range8.871 - 9.22052 Wk Range4.070 - 20.475Open / Close9.100 / -Float / Outstanding141.687M / 142.110M
Vol / Avg.1.377M / 3.117MMkt Cap1.303BP/E-50d Avg. Price6.080
Div / Yield (Forward)- / -%Payout Ratio-Total Float141.687MEPS-0.830
Adam Eckert - Jul 26, 2022, 3:50PM
InvestorsObserver - Jan 25, 2023, 5:50AM
Seeking Alpha - Nov 2, 2022, 1:41PM
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS-0.170-0.060 0.1100
REV36.180M55.779M19.599M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Aurinia Pharmaceuticals (AUPH) stock?

A

You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aurinia Pharmaceuticals's (AUPH) competitors?

A

There are no as such competitors for Aurinia Pharmaceuticals.

Q

What is the target price for Aurinia Pharmaceuticals (AUPH) stock?

A

The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Aurinia Pharmaceuticals (AUPH)?

A

The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.

Q

Does Aurinia Pharmaceuticals (AUPH) pay a dividend?

A

There are no upcoming dividends for Aurinia Pharmaceuticals.

Q

When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?

A

Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is Aurinia Pharmaceuticals (AUPH) going to split?

A

There is no upcoming split for Aurinia Pharmaceuticals.

Q

What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?

A

Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary

Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.

Loading...
Day Range8.871 - 9.22052 Wk Range4.070 - 20.475Open / Close9.100 / -Float / Outstanding141.687M / 142.110M
Vol / Avg.1.377M / 3.117MMkt Cap1.303BP/E-50d Avg. Price6.080
Div / Yield (Forward)- / -%Payout Ratio-Total Float141.687MEPS-0.830
Adam Eckert - Jul 26, 2022, 3:50PM
InvestorsObserver - Jan 25, 2023, 5:50AM
Seeking Alpha - Nov 2, 2022, 1:41PM
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS-0.170-0.060 0.1100
REV36.180M55.779M19.599M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Aurinia Pharmaceuticals (AUPH) stock?

A

You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aurinia Pharmaceuticals's (AUPH) competitors?

A

There are no as such competitors for Aurinia Pharmaceuticals.

Q

What is the target price for Aurinia Pharmaceuticals (AUPH) stock?

A

The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Aurinia Pharmaceuticals (AUPH)?

A

The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.

Q

Does Aurinia Pharmaceuticals (AUPH) pay a dividend?

A

There are no upcoming dividends for Aurinia Pharmaceuticals.

Q

When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?

A

Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is Aurinia Pharmaceuticals (AUPH) going to split?

A

There is no upcoming split for Aurinia Pharmaceuticals.

Q

What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?

A

Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary

Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.

Loading...
Day Range8.871 - 9.22052 Wk Range4.070 - 20.475Open / Close9.100 / -Float / Outstanding141.687M / 142.110M
Vol / Avg.1.377M / 3.117MMkt Cap1.303BP/E-50d Avg. Price6.080
Div / Yield (Forward)- / -%Payout Ratio-Total Float141.687MEPS-0.830
Adam Eckert - Jul 26, 2022, 3:50PM
InvestorsObserver - Jan 25, 2023, 5:50AM
Seeking Alpha - Nov 2, 2022, 1:41PM
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS-0.170-0.060 0.1100
REV36.180M55.779M19.599M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Aurinia Pharmaceuticals (AUPH) stock?

A

You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aurinia Pharmaceuticals's (AUPH) competitors?

A

There are no as such competitors for Aurinia Pharmaceuticals.

Q

What is the target price for Aurinia Pharmaceuticals (AUPH) stock?

A

The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Aurinia Pharmaceuticals (AUPH)?

A

The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.

Q

Does Aurinia Pharmaceuticals (AUPH) pay a dividend?

A

There are no upcoming dividends for Aurinia Pharmaceuticals.

Q

When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?

A

Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is Aurinia Pharmaceuticals (AUPH) going to split?

A

There is no upcoming split for Aurinia Pharmaceuticals.

Q

What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?

A

Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary

Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.

Loading...
Day Range8.871 - 9.22052 Wk Range4.070 - 20.475Open / Close9.100 / -Float / Outstanding141.687M / 142.110M
Vol / Avg.1.377M / 3.117MMkt Cap1.303BP/E-50d Avg. Price6.080
Div / Yield (Forward)- / -%Payout Ratio-Total Float141.687MEPS-0.830
Adam Eckert - Jul 26, 2022, 3:50PM
InvestorsObserver - Jan 25, 2023, 5:50AM
Seeking Alpha - Nov 2, 2022, 1:41PM
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS-0.170-0.060 0.1100
REV36.180M55.779M19.599M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Aurinia Pharmaceuticals (AUPH) stock?

A

You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aurinia Pharmaceuticals's (AUPH) competitors?

A

There are no as such competitors for Aurinia Pharmaceuticals.

Q

What is the target price for Aurinia Pharmaceuticals (AUPH) stock?

A

The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Aurinia Pharmaceuticals (AUPH)?

A

The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.

Q

Does Aurinia Pharmaceuticals (AUPH) pay a dividend?

A

There are no upcoming dividends for Aurinia Pharmaceuticals.

Q

When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?

A

Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is Aurinia Pharmaceuticals (AUPH) going to split?

A

There is no upcoming split for Aurinia Pharmaceuticals.

Q

What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?

A

Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary

Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.

Loading...
Day Range8.871 - 9.22052 Wk Range4.070 - 20.475Open / Close9.100 / -Float / Outstanding141.687M / 142.110M
Vol / Avg.1.377M / 3.117MMkt Cap1.303BP/E-50d Avg. Price6.080
Div / Yield (Forward)- / -%Payout Ratio-Total Float141.687MEPS-0.830
Adam Eckert - Jul 26, 2022, 3:50PM
InvestorsObserver - Jan 25, 2023, 5:50AM
Seeking Alpha - Nov 2, 2022, 1:41PM
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS-0.170-0.060 0.1100
REV36.180M55.779M19.599M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Aurinia Pharmaceuticals (AUPH) stock?

A

You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aurinia Pharmaceuticals's (AUPH) competitors?

A

There are no as such competitors for Aurinia Pharmaceuticals.

Q

What is the target price for Aurinia Pharmaceuticals (AUPH) stock?

A

The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 19.96% upside). 13 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Aurinia Pharmaceuticals (AUPH)?

A

The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.17 last updated Today at February 1, 2023 at 8:03 PM UTC.

Q

Does Aurinia Pharmaceuticals (AUPH) pay a dividend?

A

There are no upcoming dividends for Aurinia Pharmaceuticals.

Q

When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?

A

Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is Aurinia Pharmaceuticals (AUPH) going to split?

A

There is no upcoming split for Aurinia Pharmaceuticals.

Q

What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?

A

Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.